SynthesisAmerican journal of Alzheimer's disease and other dementias2013
Alzheimer's disease dementia guidelines for diagnostic testing: a systematic review.
Synthesis in American journal of Alzheimer's disease and other dementias, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 8 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 8 syntheses or guidelines pooled it.
- Management of Inpatient Elevated Blood Pressures : A Systematic Review of Clinical Practice Guidelines.Annals of internal medicine · 2024Pooled it
- Recommendations of high-quality clinical practice guidelines related to the process of starting dialysis: A systematic review.PloS one · 2022Pooled it
- Protection against discrimination in national dementia guideline recommendations: A systematic review.PLoS medicine · 2022Pooled it
- Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI).The Cochrane database of systematic reviews · 2021Pooled it
- Quality assessment of clinical practice guidelines for chronic kidney disease: a systematic review.BMC nephrology · 2019Pooled it
- Pooled it
- Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).The Cochrane database of systematic reviews · 2015Pooled it
- Do guidelines offer implementation advice to target users? A systematic review of guideline applicability.BMJ open · 2015Pooled it
- Towards a Multidimensional Model of Neurocognitive Disorders (MOND Model): Integrating Evidence from a Critical Review into a Model for Future Research.Journal of personalized medicine · 2026Review
- The role of general practitioners in dementia diagnosis: a scoping review of clinical practice guidelines.Family practice · 2025Article
- Guideline recommendations on the role of the general practitioner in the diagnosis of dementia: a protocol for a scoping review of clinical practice guidelines.HRB open research · 2024Article
- Association between cardiovascular risk factors and cognitive impairment in adults aged 60 years or older from Chile: a cross-sectional study.BMC geriatrics · 2023Article
- A Systematic Review of Clinical Practice Guidelines for Alzheimer's Disease and Strategies for Future Advancements.Neurology and therapy · 2023Article
- COVID-19 therapies for inpatients: a review and quality assessment of clinical guidelines.ERJ open research · 2022Review
- Quality of recent clinical practice guidelines in anaesthesia publications using the Appraisal of Guidelines for Research and Evaluation II instrument.British journal of anaesthesia · 2022Review
- Recommendations for the pharmacological treatment of treatment-resistant depression: A systematic review protocol.PloS one · 2022Article
- The Italian Version of the Test Your Memory (TYM-I): A Tool to Detect Mild Cognitive Impairment in the Clinical Setting.Frontiers in psychology · 2020Article
- Article
- Guideline appraisal with AGREE II: online survey of the potential influence of AGREE II items on overall assessment of guideline quality and recommendation for use.BMC health services research · 2018Article
- Angiotensin II, hypertension and angiotensin II receptor antagonism: Roles in the behavioural and brain pathology of a mouse model of Alzheimer's disease.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alzheimer's disease dementia (AD dementia) is one of the most common neurodegenerative diseases worldwide, with a growing incidence during the last decades. Clinical diagnosis of cognitive impairment and presence of AD biomarkers have become important issues for early and adequate treatment. We performed a systematic literature search and quality appraisal of AD dementia guidelines, published between 2005 and 2011, which contained diagnostic recommendations on AD dementia. We also analyzed diagnostic recommendations related to the use of brief cognitive tests, neuropsychological evaluation, and AD biomarkers. Of the 537 retrieved references, 15 met the selection criteria. We found that Appraisal of Guidelines Research and Evaluation (AGREE)-II domains such as applicability and editorial independence had the lowest scores. The wide variability on assessment of quality of evidence and strength of recommendations were the main concerns identified regarding diagnostic testing. Although the appropriate methodology for clinical practice guideline development is well known, the quality of diagnostic AD dementia guidelines can be significantly improved.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.